SiMPl-GS and SiMPl-DHFR: advancing cell line development via synthetic selection markers for next-generation biopharmaceutical production

Authors

• Gyun Min Lee, KAIST, South KoreaFollow
• Chansik Yoon, Dept. of Biological Sciences, KAIST, Daejeon, Republic of Korea
• Eun-Ji Lee, Biotherapeutics Translational Research Center, KRIBB, Daejeon, Republic of Korea
• Yujin Kim, Dept. of Biological Sciences, KAIST, Daejeon, Republic of Korea
• Siyun Joung, Dept. of Biological Sciences, KAIST, Daejeon, Republic of Korea
• Dongil Kim, Dept. of Biological Sciences, KAIST, Daejeon, Republic of Korea
• Heungchae Jung, BIO Center, Daejeon Technopark, Daejeon, Republic of Korea
• Yeon-Gu Kim, Biotherapeutics Translational Research Center, KRIBB, Daejeon, Republic of Korea

Conference Dates

April 27 - May 2, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Gyun Min Lee, Chansik Yoon, Eun-Ji Lee, Yujin Kim, Siyun Joung, Dongil Kim, Heungchae Jung, and Yeon-Gu Kim, "SiMPl-GS and SiMPl-DHFR: advancing cell line development via synthetic selection markers for next-generation biopharmaceutical production" in "Cell Culture Engineering XIX", A Khetan, BMS; Marcella Yu, Gilead; Mike Betenbaugh, Johns Hopkins University Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/cell_culture_engineering_xix/104